SNDX
HEALTHYSyndax Pharmaceuticals Inc
CIK: 0001395937
Strong Sell
(50% confidence)
Last activity: 5 days ago
Financial Metrics
As of Dec 31, 2024 (10-K)
Revenue $23.68M
Net Income -$209.36M
Total Cash $452.57M
Total Debt $337.88M
Debt/Equity 1.17
Insider Roster (2 total, 2 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| Metzger Michael A Chief Executive Officer | 0 | 2 | -$514K | 491,690 shares $10.34M |
| Goldan Keith A. Chief Financial Officer | 0 | 2 | -$115K | 140,429 shares $2.95M |
Recent Transactions
SELL Metzger Michael A (Chief Executive Officer)
17,159 shares @ $21.03
$361K
Feb 9, 2026
Conviction: |
View SEC Filing →
SELL Goldan Keith A. (Chief Financial Officer)
3,410 shares @ $21.03
$72K
Feb 9, 2026
Conviction: |
View SEC Filing →
SELL Metzger Michael A (Chief Executive Officer)
7,412 shares @ $20.62
$153K
Feb 6, 2026
Conviction: |
View SEC Filing →
SELL Goldan Keith A. (Chief Financial Officer)
2,082 shares @ $20.62
$43K
Feb 6, 2026
Conviction: |
View SEC Filing →
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.